1. Home
  2. CHYM vs BAX Comparison

CHYM vs BAX Comparison

Compare CHYM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chime Financial Inc.

CHYM

Chime Financial Inc.

N/A

Current Price

$32.41

Market Cap

12.0B

Sector

Finance

ML Signal

N/A

Logo Baxter International Inc.

BAX

Baxter International Inc.

N/A

Current Price

$25.98

Market Cap

13.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHYM
BAX
Founded
2012
1931
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
13.4B
IPO Year
2025
1994

Fundamental Metrics

Financial Performance
Metric
CHYM
BAX
Price
$32.41
$25.98
Analyst Decision
Strong Buy
Hold
Analyst Count
23
15
Target Price
★ $42.38
$27.25
AVG Volume (30 Days)
4.7M
★ 6.8M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
★ 0.16%
EPS Growth
N/A
★ N/A
EPS
0.31
★ 0.78
Revenue
$2,186,770,000.00
★ $11,244,000,000.00
Revenue This Year
$28.06
$4.27
Revenue Next Year
$23.18
$2.01
P/E Ratio
$106.23
★ $33.04
Revenue Growth
★ 30.69
5.72
52 Week Low
$15.88
$15.73
52 Week High
$35.55
$30.00

Technical Indicators

Market Signals
Indicator
CHYM
BAX
Relative Strength Index (RSI) 57.45 55.56
Support Level $30.95 $25.75
Resistance Level $33.41 $25.99
Average True Range (ATR) 1.37 0.98
MACD 0.27 0.01
Stochastic Oscillator 66.43 75.49

Price Performance

Historical Comparison
CHYM
BAX

About CHYM Chime Financial Inc.

Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.

About BAX Baxter International Inc.

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Share on Social Networks: